Remote Second Opinion from MD Anderson Experts for a Cancer Patient - a Case Study
- Medebound HEALTH
- Jul 6, 2025
- 6 min read
Updated: Dec 29, 2025
Author: Medical Editor Iris
Content
A Global Online Second Opinion Collaboration for a Cancer Patient in Asia
Cancers have long posed daunting challenges to both doctors and patients.
In this notable international case, a top expert from MD Anderson Cancer Center in the U.S. and a leading surgeon from Peking Union Medical College Hospital (PUMCH, ranked #1 in China) worked together. They developed a potential curative treatment plan for a patient with a recurring yolk sac tumor.
Medebound HEALTH facilitated the cross-border video consultation/second opinion, handled complex logistics, and delivered compassionate, professional services that were highly appreciated by the patient and her family.
Patient Overview
Patient: Ms. Lin (alias), 33 years old
Primary Concern: Seeking a second opinion from MD Anderson
Local Hospital: Peking Union Medical College Hospital (PUMCH), Beijing
Diagnosis: Recurrent yolk sac tumor post-surgery
US Expert: MD Anderson rare ovarian cancer specialist
Proposed Second Opinion Plan: High-dose chemotherapy + originated stem transplantation
Curative Rate: Estimated 30%–50%, potentially higher
Patient Outcome: Highly satisfied; considering overseas treatment
Understanding Yolk Sac Tumors
Yolk sac tumors are rare ovarian germ cell tumors usually found in younger women aged 10–30. Though the exact cause is unknown, factors such as genetic mutations, chromosomal abnormalities, and syndromes like Swyer syndrome may play a role. Due to their rarity and aggressive nature, treatment often requires specialized, high-dose regimens unavailable in most countries.
The Journey: From Asia to Second Opinion at MD Anderson via Medebound HEALTH
Ms. Lin (alias, to protect patient's privacy) had already undergone three surgeries and six rounds of chemotherapy, only to face another recurrence of her tumor. Treated initially by Professor Yang(alias), a highly respected ovarian cancer surgeon at PUMCH, her options were becoming limited.
Recalling a rare tumor expert he met during a U.S. fellowship, Prof. Yang encouraged Ms. Lin to seek a second opinion from MD Anderson. After unsuccessful direct contact, Ms. Lin’s family turned to Medebound HEALTH.
Founded in 1941 and located in Houston, Texas, MD Anderson is a globally leading comprehensive cancer center, ranked No. 1 in the U.S. for cancer care multiple times. It was among the first cancer centers designated by the U.S. government under the 1971 National Cancer Act.
Recognized by Forbes, Medebound HEALTH has been trusted by Fortune 500 and used by thousands of affluent families worldwide. Learn More Here.
The Medebound Solution: Fast, Accurate, Global
Upon receiving Ms. Lin’s request, Medebound HEALTH international medical team swiftly reviewed her history, secured her preferred MD Anderson expert, and even offered an alternative from Memorial Sloan Kettering Cancer Center. Within just one week, a cross-border video consultation was arranged.
Consultation Highlights
Date: May 16, 2023, 8:00 PM EST
Location: Virtual meeting room with PUMCH’s Prof. Yang and team present
Language & Records: All records translated and 5 key questions prepared by Medebound HEALTH
Additional Scans: U.S. expert requested PET/CT from a top-tier Chinese hospital
A key highlight was the clinical discussion between Prof. Yang and the MD Anderson expert:
Consideration of surgical removal of hypermetabolic nodules
Consensus: Surgery not recommended due to prior radiation and location
Expert Second Opinion
After detailed review, the MD Anderson expert ruled out targeted and immunotherapies due to lack of actionable mutations. Instead, they proposed a bold, potentially curative regimen:
High-dose chemotherapy with etoposide and carboplatin
Followed by autologous originated stem cell transplantation
This therapy is only available in specialized U.S. centers, offering 30%–50% cure rates, higher in some cases.
Post-Consultation: Report & Response
Two days later, Medebound HEALTH delivered a bilingual written report summarizing all expert opinions and recommendations.
Patient feedback:
“Professional, warm, efficient, more than what we hoped for. We are excited about the curative possibility that we have never learned locally!”
Recognized by Forbes, Medebound HEALTH has been trusted by Fortune 500 and used by thousands of affluent families worldwide. Learn More Here.
Why U.S. Access Matters for Difficult or Rare Tumors
The U.S. is a global leader in cancer innovation:
Over 50% of new drugs are developed in the U.S.
Global patients often face 3–5 year delays for approval
For rare tumors, that delay can be 5–10 years
In this case, we demonstrated:
Global teamwork between leading U.S. and Asian specialists
Access to top US expertise that is not available locally
Prompt cross-border coordination by Medebound HEALTH
Patient-centric care driven by compassion and accuracy
Medebound HEALTH - Our integrative approach
Comparison: Getting a U.S. Second Opinion from Experts at MD Anderson, Cost and others
Alternative Approaches | MD Anderson on-site second opinion | Medebound HEALTH Remote Second Opinion |
Doctor Level | Un-determined | Top director-level specialists matched to your case from Top 3 Cancer Centers (including MD Anderson, Memorial Sloan Kettering, Dana Farber) |
Timeline | 2-3 weeks+ travel time | As fast as 5-7 days |
Cost | often quoted for ~$30,000+ (travel + lodging) | $2,000–$6,000 (all-inclusive) |
Consultation Format | In-person only | Written or Video Second Opinions |
Language Support | On site support | Full medical translation included |
Follow-up Support | Additional on-site appointments needed | Long term online follow-up service is supported - can consult the physician for a long period of time, not just one-off second opinion |
Convenience | Requires long-distance travel | Fully managed process, no travel needed. Consider travelling when there is differentiated service |
With over 9 years of experience, Medebound HEALTH offers:
Medical history collection/translation/organization
Matching with Top 3 Cancer Hospitals's U.S. experts - including those from MD Anderson, MSK and Dana Farber
Remote Virtual Second Opinion - Video + Written
Named patient access to U.S. therapies
If needed, U.S.-based treatment logistics
End-to-end support
Important Considerations:
Insurance Coverage: Check with your insurance provider regarding coverage for second opinion consultations, as many may not cover the cost.
Second Opinion Limitation: U.S. second opinion consultations are for reference purposes only. The physician-patient relationship is not formed with your remote physician. Remote consultations differ from in-person visits and are subject to limitations due to lack of direct in-person examination. As such you will need to understand Medebound HEALTH and the U.S. doctor are not liable for any treatment decisions made based on the second opinion, and accept the risks of relying on any information provided under this agreement. You will need to sign an agreement to confirm that you voluntarily request this service and understand its limitations.
Timeliness: Getting a second opinion early in your treatment journey, ideally before starting treatment, can be beneficial.
Frequently Asked Questions (FAQs) About MD Anderson
1. Can I get an online second opinion for cancer from doctors at Top Centers without traveling?
Yes. We offer a secure remote cancer consultation service that allows international patients to receive expert oncology advice without visiting the U.S. Top Centers in person.
2. What is included in a second opinion through Medebound HEALTH?
Patients receive a thorough review of their existing diagnosis and treatment plan by a leading MD Anderson cancer specialist. This may include a written report, molecular or pathology review, and recommendations for advanced therapies or clinical trials.
3. How do international patients request a second opinion from experts at MD Anderson?
Through Medebound HEALTH, patients can submit their medical records online, make payment securely, and receive guidance throughout the process including translation services if needed.
4. What types of cancer can be reviewed remotely by MD Anderson physicians?
We provide virtual second opinions for nearly all major cancers, including breast, lung, liver, pancreatic, prostate and rare tumors.
5. How long does it take to receive a remote second opinion for cancer?
Once medical records are complete, patients typically receive their online second opinion from MD Anderson within 7 business days.
How to Apply
You are looking for clarity, confidence, and expert insight from world-class cancer doctors without the pain of international travel.
Medebound HEALTH is designed to provide precisely that:
Access to U.S. expert insights,
Fast turnaround so treatment decisions aren’t delayed,
Support through coordination, translation, and expert matching.
Email: support@medeboundhealth.com
Website: www.medeboundhealth.com
WhatsApp: click HERE Submit the form: Click HERE we will get back within 4 hours Instant Chat: Click the chat button at the lower right corner of this page👇
About Medebound HEALTH: Since 2016, we've helped thousands of affluent families mostly from Asia get personalized cancer remote second opinions from the top 1% of US hospitals through simple written opinion or video calls. These are the same top doctors trained or active at top hospitals such as MD Anderson, Mayo Clinic, Memorial Sloan Kettering and Johns Hopkins, etc, you will get their expertise, their treatment suggestion, and their guidance - all from your home. No matter where you live, world-class cancer care is just a few steps away.
Disclaimer
We strive to maintain the accuracy and provide regular updates for the treatment information described in this article. However, treatment outcomes may vary between individuals. The information provided here is not intended as a diagnostic or treatment recommendation and should not replace the careful evaluation and advice of your attending physician. The service is independently operated by Medebound HEALTH and is not provided, partnered, or affiliated with any hospital center as an institution.
Comments